The Biomedical Ultrasonics, Biotherapy & Biopharmaceuticals Laboratory (BUBBL)
was founded in October 2004 and forms part of the Institute of Biomedical Engineering and the Department of Engineering Science at the University of Oxford. Its focus is the application of sound principles of acoustics, fluid mechanics and control to investigate a wide array of emerging diagnostic and therapeutic ultrasound applications, ranging from non-invasive therapy to targeted drug delivery, in order to enable the transition of such techniques into the clinical arena [read more...]
The Laboratory is home to state-of-the-art calibration and characterization facilities for diagnostic and therapeutic ultrasound. Currently available expertise ranges from techniques for active and passive cavitation monitoring and control for a variety of applications, including High-Intensity Focussed Ultrasound (HIFU), to the development of new techniques for utrasound-enhanced, targeted drug delivery. Novel high-frequency acoustic microscopy techniques are also being developed for cell and drug particle characterization, whilst ultrasound standing waves and acoustic resonators are being utilized for particle separation and acoustic filtration.